Receptor mechanisms of antipsychotic drug atypicality

European Psychiatry

Volumn 13, Issue SUPPL.1, 1998, Pages

  Reynolds, G P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Antipsychotics; Atypicality; Receptors; Schizophrenia

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CHOLINERGIC RECEPTOR; CLOZAPINE; DOPAMINE RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; REMOXIPRIDE; RISPERIDONE; SEROTONIN RECEPTOR; SULPIRIDE;

ALPHA ADRENERGIC RECEPTOR BLOCKING; CHOLINERGIC RECEPTOR BLOCKING; CONFERENCE PAPER; DOPAMINE RECEPTOR BLOCKING; DRUG ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; EXTRAPYRAMIDAL SYMPTOM; HUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SCHIZOPHRENIA;

EID: 0031930412     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(97)89487-4     Document Type: Article

References (12)

1. Bakshi V, Geyer MA. Antagonism of PP-induced deficits prepulse inhibition by olanzapine (abstract). Soc Neurosci Abstr 1995;21:1707
2. 2-adrenoceptor subtypes in postmortem human brain. J Psychopharmacol 1996;10(Suppl):A7
3. Corrigan FM, MacDonald S, Reynolds GP. Clozapine-induced hypersalivation and the alpha 2 adrenoceptor. Br J Psychiatry 1995;167:412
4. 2 -dopamine receptor occupancy in patients treated with classical antipsychotics and clozapine. Arch Gen Psychiatry 1992;49:538-44
5. 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study. J Clin Pharmacol 1993;13:264-7
6. Litman RE, Su TP, Potter WZ, Hong WW, Pickar D. Idazoxan and response to typical antipsychotics in treatment-resistant schizophrenia. Comparison with the atypical antipsychotic, clozapine. Br J Psychiatry 1996;168:571-9
7. 123I] IBZM single photon emission tomography (SPET) study. Psychopharmacol 1996; 124:148-53
8. Reynolds GP. Neurotransmitter systems in schizophrenia. Int Rev Neurobiol 1995;28:305-39
9. 4 receptors in the action and development of antipsychotic agents. Drugs 1996;51:7-11
10. Reynolds GP, Czudek C. New approaches to the drug treatment of schizophrenia. Adv Pharmacol 1995;32:461-503
11. Robertson GS, Matsumara H, Fibiger HC. Induction patterns of foslike immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 1994;271:1058-66
12. White FJ, Wang RY. Differential effects of classical and atypical antipsychotic drugs on A9 and AlO dopamine neurones. Science 1983;221:1054-7